The University of Chicago Header Logo

Chimeric antigen receptor T-cell therapy in secondary central nervous system lymphoma: A multicenter analysis.

Chimeric antigen receptor T-cell therapy in secondary central nervous system lymphoma: A multicenter analysis. Am J Hematol. 2024 May 20.

View in: PubMed